An unusual case of chronic neuropathic pain responds to an optimum frequency of intravenous ketamine infusions.

This publication has 9 references indexed in Scilit:

• The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial
  Pain, 1998
• NMDA receptors are important for both mechanical and thermal allodynia from peripheral nerve injury in rats
  NeuroReport, 1997
• High‐dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia
  Neurology, 1997
• New Pharmacological Strategies for Pain Relief
  Annual Review of Pharmacology and Toxicology, 1996
• Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient
  Journal of Pain and Symptom Management, 1995
• Relief of post-herpetic neuralgia with the Symbol receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo
  Pain, 1994
• Response of chronic neuropathic pain syndromes to ketamine: a preliminary study
  Pain, 1994
• MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy
  Brain Research, 1991
• Immediate and long-term phantom limb pain in amputees: Incidence, clinical characteristics and relationship to pre-amputation limb pain
  Pain, 1985